Journal of Nuclear Medicine April 2025, jnumed.125.269670; DOI: https://doi.org/10.2967/jnumed.125.269670 ...

[18 F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies ...

Journal of Nuclear Medicine March 2025, jnumed.124.268175; DOI: https://doi.org/10.2967/jnumed.124.268175 ...

Radiopharmaceuticals for PET imaging are regulated as drugs by the U.S. Food and Drug Administration (FDA) through several offices within the Center for Drug Evaluation and Research, including the ...

Nuclear cardiology offers a diverse range of imaging tools that provide valuable insights into myocardial perfusion, inflammation, metabolism, neuroregulation, thrombosis, and microcalcification.

Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1529; ...

Journal of Nuclear Medicine April 2025, jnumed.124.268859; DOI: https://doi.org/10.2967/jnumed.124.268859 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Objectives Bone is the most frequent site of breast cancer metastases.Considering many breast cancer patients are old age,bone is likely affected by degenerative or inflammatory bone disease.Recently ...

Until the Surgical Treatment for Ischemic Heart Failure (STICH) viability study (10), only 1 randomized study (11) investigated whether evaluation of viability using PET to select patients with LV ...

Objectives The selective A2A adenosine receptor agonist regadenoson is approved as a pharmalogical stress agent for detecting reversible myocardial hypoperfusion. Regadenoson has a more rapid onset of ...